Search for a trial

A Phase Ib/II, Multicentre, Open Label, Randomized Study of BI 836845 in Combination With Enzalutamide, versus Enzalutamide alone, in Metastatic Castration-Resistant Prostate Cancer (CRPC) Following Disease Progression on Docetaxel-Based Chemotherapy and Abiraterone

To compare treatment with enzaluatmide plus BI836845 with treatment with enzalutamide only.

Embolisation of the prostatic artery in patients with symptomatic benign prostate hyperplasia:
A prospective single arm cohort-study.

The assess the safety and efficacy of prostate artery embolization (PAE) with polyethylene glycol microspheres (PEGM) in patients with low urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH).